Peter Oppenheimer, the chief of global equity strategy and the head of macro research for Goldman Sachs in Europe, opined ...
Bernstein SocGen Group revised its price target for Regeneron (NASDAQ:REGN) Pharmaceuticals (NASDAQ: REGN) to $1,000 from the previous $1,070, while retaining an Outperform rating on the stock.
Alternative lending giant Goldman Sachs Asset Management is looking to raise as much as $3 billion for a new climate credit ...
Goldman Sachs analyst Neil Mehta downgraded Occidental Petroleum (OXY – Research Report) to a Sell today and set a price target of $45.00. The ...
This analysis is by Bloomberg Intelligence Senior Analyst Alison Williams and Analyst Neil Sipes. It appeared first on the ...
Goldman Sachs downgrades Occidental Petroleum to Sell, citing focus on balance sheet improvements over capital returns.